PharmaBlock Sciences (Nanjing), Inc. (SHE:300725)

SHE:300725 Revenue

PharmaBlock Sciences (Nanjing) had revenue of 551.43M CNY in the quarter ending June 30, 2026, with 18.66% growth. This brings the company's total for the last twelve months to 2.11B, up 13.45% year-over-year. In the year 2025, PharmaBlock Sciences (Nanjing) had annual revenue of 1.97B with 16.93% growth. That makes PharmaBlock Sciences (Nanjing) the 14,141st largest company in the world by revenue and 2,522nd in China.

• Revenue (ttm): 2.11B
• Revenue Growth: +13.45%
• P/S Ratio: 4.56
• Revenue / Employee: 815.35K
• Employees: 2,593
• Market Cap: 10.21B

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• Foreign 1.43B 72.7%
• China 539.88M 27.3%

Fiscal year ended Dec 31, 2025 See the full SHE:300725 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.97B	285.86M	16.93%
Dec 31, 2024	1.69B	-36.58M	-2.12%
Dec 31, 2023	1.73B	130.50M	8.18%
Jan 1, 2023	1.59B	393.07M	32.71%
Dec 31, 2021	1.20B	179.40M	17.55%

Data Source: S&P Global Market Intelligence Last updated: Aug 10, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 28, 2026

Data Sources Report a data error